TERN
TernsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TERN Profile
Terns Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company that develops small-molecule products for serious diseases, including oncology, obesity and NASH
1065 East Hillsdale Blvd., Suite 100, Foster City, California 94404
--
Terns Pharmaceuticals, Inc., was incorporated under the laws of the Cayman Islands on December 9, 2016. On December 29, 2020, the Company was deregistered under the Cayman Islands Corporation Law (2020 Revision) and naturalized under Section 388 of the Delaware General Corporation Law (by filing a certificate of naturalization with the Secretary of State of Delaware), pursuant to which its jurisdiction of incorporation was changed from Cayman Islands to Delaware, TernsPharmaceuticals Inc., a clinical-stage biopharmaceutical company, Develop a range of small molecule product candidates to address serious diseases, including oncology and obesity.
